Key facts
- This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jul 2022, 20:00.
Marcus Schulz - 22 Jul 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- Chief Revenue Officer
- Issuer ticker
- BLFS
- Reported as of
- 22 Jul 2022
- Net transaction value
- -$6,584
- SEC form
- 4
- Accepted by SEC
- 26 Jul 2022, 20:00:24 UTC
- Prior SEC filing
- 14 Jul 2022
- Next SEC filing
- 05 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marcus Schulz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 26 Jul 2022.
Change
- Previous filing in this sequence was filed on 14 Jul 2022.
- Current net transaction value: -$6,584.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Sale
- Transaction value
- $6,584
- Shares
- -367
- Change %
- -0.89%
- Price
- $17.94
- Shares after
- 40,818
- Date
- 22 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.